Liz Parrish Releases How I Became a GMO and Why You Will Too, a Firsthand Account of Gene Therapy, Aging, and the Future of Human Longevity
BioViva CEO shares the personal journey that led her from searching for answers to her son's Type 1 diabetes to becoming one of the first people to undergo experimental gene therapies targeting biological aging.
PACIFIC, Wash., Oct. 27, 2026 /PRNewswire/ -- Elizabeth "Liz" Parrish, founder and CEO of BioViva Sciences USA Inc., announces the release of her new book, How I Became a GMO and Why You Will Too: A Manifesto for Human Longevity. Blending personal memoir, biotechnology, and a challenge to conventional thinking about medicine, Parrish tells the story behind her decision to pursue experimental gene therapies targeting biological aging and her vision for a future focused on preventing disease and extending healthy human life.
The journey began when Parrish's son was diagnosed with Type 1 diabetes. Determined to explore possibilities beyond managing disease, she immersed herself in stem-cell research, regenerative medicine, and gene therapy. That search ultimately led her to become one of the first people to personally undergo experimental gene therapies intended to address aspects of biological aging.
In the book, Parrish shares the personal risks, scientific questions, public scrutiny, and difficult decisions that have shaped her work. She explores the biology of aging, telomeres, gene therapy, regenerative medicine, and emerging technologies that may change how society approaches age-related disease.
"This book is the story of how a mother's search for better answers led me into the world of biotechnology and changed the direction of my life," says Parrish. "I wrote it to share what I have learned, the risks I have taken, and why I believe we should be asking bigger questions about aging, disease, and what medicine might make possible in the future."
As CEO of BioViva Sciences USA Inc., Parrish advocates for the development of genetic therapies aimed at age-related diseases and for rethinking how promising medical innovations can be evaluated and made accessible. Her proposed Best Choice Medicine framework reflects her interest in developing new approaches to medical decision-making and access to emerging therapies.
How I Became a GMO and Why You Will Too is both a personal account and a call to reconsider the future of healthcare. Parrish invites readers to engage with the promise of biotechnology while confronting the scientific, ethical, regulatory, and societal questions that accompany efforts to change human biology.
The book is available in paperback, hardcover, and ebook formats.
Where to Buy
- Paperback: https://www.lulu.com/shop/elizabeth-parrish/how-i-became-a-gmo-and-why-you-will-too/paperback/product-v8nw8ky.html
- Hardcover: https://www.lulu.com/shop/elizabeth-parrish/how-i-became-a-gmo-and-why-you-will-too/hardcover/product-m2v4dvn.html
- Ebook (EPUB): https://www.lulu.com/shop/elizabeth-parrish/how-i-became-a-gmo-and-why-you-will-too/ebook/product-q67wgwj.html
About Elizabeth "Liz" Parrish
Elizabeth "Liz" Parrish, MBA, is the founder and CEO of BioViva Sciences USA Inc., a biotechnology company focused on extending healthy human lifespans through gene therapy. Since 2015, Parrish has pursued experimental gene therapies targeting aspects of biological aging, making her a prominent figure in the longevity field. Her work focuses on combinatorial gene therapies, age-related disease, regenerative medicine, and new approaches to medical innovation.
Through her writing and international speaking engagements, Parrish encourages public discussion about the potential of biotechnology to transform medicine and the responsibilities that accompany scientific progress.
Media Contact
Parrish Consulting
HowIBecameAGMO.com
Book: How I Became a GMO and Why You Will Too: A Manifesto for Human Longevity
Author: Elizabeth "Liz" Parrish
ISBN (Paperback): 9798997894818
ISBN (Hardcover): 9798997894801
ISBN (Ebook): 9798997894825
SOURCE BioViva USA Inc.
Share this article